Cidara Therapeutics, Inc. – NASDAQ:CDTX

Cidara Therapeutics stock price today

$61
+37.31
+157.49%
Financial Health
0
1
2
3
4
5
6
7
8
9

Cidara Therapeutics stock price monthly change

+106.36%
month

Cidara Therapeutics stock price quarterly change

+106.36%
quarter

Cidara Therapeutics stock price yearly change

+2868.67%
year

Cidara Therapeutics key metrics

Market Cap
165.31M
Enterprise value
51.01M
P/E
-2.62
EV/Sales
0.65
EV/EBITDA
-0.86
Price/Sales
1.06
Price/Book
-28.38
PEG ratio
-0.05
EPS
-8.14
Revenue
46.37M
EBITDA
-38.11M
Income
-36.46M
Revenue Q/Q
-67.43%
Revenue Y/Y
-44.23%
Profit margin
-78.85%
Oper. margin
-78.71%
Gross margin
0%
EBIT margin
-78.71%
EBITDA margin
-82.18%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cidara Therapeutics stock price history

Cidara Therapeutics stock forecast

Cidara Therapeutics financial statements

Cidara Therapeutics, Inc. (NASDAQ:CDTX): Profit margin
Jun 2023 7.61M -12.35M -162.29%
Sep 2023 12.71M -8.17M -64.26%
Dec 2023 17.58M -5.61M -31.91%
Mar 2024 8.46M -10.32M -122.01%
Cidara Therapeutics, Inc. (NASDAQ:CDTX): Analyst Estimates
2025 42.85M -39.42M -92%
2026 53.24M -33.31M -62.57%
2027 138.05M 47.12M 34.13%
2028 104.97M 24.08M 22.95%
  • Analysts Price target

  • Financials & Ratios estimates

Cidara Therapeutics, Inc. (NASDAQ:CDTX): Debt to assets
Jun 2023 67986000 52.57M 77.33%
Sep 2023 63468000 55.43M 87.34%
Dec 2023 68530000 76.74M 111.98%
Mar 2024 52716000 70.49M 133.73%
Cidara Therapeutics, Inc. (NASDAQ:CDTX): Cash Flow
Jun 2023 2.82M -107K -261K
Sep 2023 -1.63M -126K 0
Dec 2023 -12.72M -178K 8K
Mar 2024 -6.64M -23K -93K

Cidara Therapeutics alternative data

Cidara Therapeutics, Inc. (NASDAQ:CDTX): Employee count
Sep 2023 73
Oct 2023 73
Nov 2023 73
Dec 2023 73
Jan 2024 73
Feb 2024 73
Mar 2024 73
Apr 2024 73
May 2024 69
Jun 2024 69
Jul 2024 69

Cidara Therapeutics other data

57.79% -4.98%
of CDTX is owned by hedge funds
30.31M -780.92K
shares is hold by hedge funds

Cidara Therapeutics, Inc. (NASDAQ:CDTX): Insider trades (number of shares)
Period Buy Sel
Mar 2024 0 81095
Jun 2024 8000 0
Sep 2024 0 1833
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SANDISON TAYLOR officer: Chief Me.. Common Stock 924 $11.64 $10,753
Sale
TARI LESLIE officer: CHIEF SCIENTIFIC OFFICER
Common Stock 909 $11.64 $10,580
Purchase
STEIN JEFFREY director, officer.. Common Stock 8,000 $13.21 $105,680
Sale
TARI LESLIE officer: CHIEF SCIENTIFIC OFFICER
Common Stock 21,029 $0.67 $14,089
Sale
SANDISON TAYLOR officer: Chief Me.. Common Stock 20,662 $0.67 $13,844
Sale
WARD SHANE officer: COO & CLO
Common Stock 20,473 $0.67 $13,717
Sale
SHAH PREETAM officer: CFO & CBO
Common Stock 18,931 $0.67 $12,684
Sale
TARI LESLIE officer: CHIEF SCIENTIFIC OFFICER
Common Stock 18,469 $0.95 $17,509
Sale
SANDISON TAYLOR officer: Chief Me.. Common Stock 18,793 $0.95 $17,816
Purchase
TARI LESLIE officer: CHIEF SCIENTIFIC OFFICER
Common Stock 10,000 $0.97 $9,700
Patent
Application
Filling date: 21 Apr 2021 Issue date: 18 Aug 2022
Application
Filling date: 18 Feb 2022 Issue date: 9 Jun 2022
Application
Filling date: 25 Oct 2019 Issue date: 18 Nov 2021
Application
Filling date: 5 Mar 2021 Issue date: 29 Jul 2021
Application
Filling date: 5 Mar 2021 Issue date: 22 Jul 2021
Application
Filling date: 14 Jun 2019 Issue date: 17 Jun 2021
Application
Filling date: 2 Jul 2020 Issue date: 6 May 2021
Application
Filling date: 29 Nov 2017 Issue date: 7 Jan 2021
Grant
Filling date: 1 Aug 2019 Issue date: 22 Sep 2020
Application
Filling date: 11 Jul 2018 Issue date: 27 Aug 2020
Tuesday, 3 December 2024
zacks.com
Thursday, 21 November 2024
seekingalpha.com
globenewswire.com
Tuesday, 19 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Thursday, 31 October 2024
globenewswire.com
Friday, 4 October 2024
globenewswire.com
Wednesday, 25 September 2024
globenewswire.com
Monday, 23 September 2024
globenewswire.com
Thursday, 19 September 2024
globenewswire.com
Thursday, 12 September 2024
globenewswire.com
Thursday, 5 September 2024
globenewswire.com
Monday, 19 August 2024
globenewswire.com
Tuesday, 13 August 2024
globenewswire.com
Wednesday, 3 July 2024
globenewswire.com
Thursday, 30 May 2024
globenewswire.com
Wednesday, 15 May 2024
globenewswire.com
globenewswire.com
Friday, 10 May 2024
prnewswire.com
Friday, 26 April 2024
seekingalpha.com
globenewswire.com
Thursday, 25 April 2024
businesswire.com
Wednesday, 24 April 2024
Market Watch
Tuesday, 26 December 2023
Zacks Investment Research
Thursday, 30 November 2023
GlobeNewsWire
Friday, 22 September 2023
Seeking Alpha
Wednesday, 6 September 2023
GlobeNewsWire
Proactive Investors
Monday, 28 August 2023
InvestorPlace
Thursday, 10 August 2023
Seeking Alpha
  • What's the price of Cidara Therapeutics stock today?

    One share of Cidara Therapeutics stock can currently be purchased for approximately $61.

  • When is Cidara Therapeutics's next earnings date?

    Unfortunately, Cidara Therapeutics's (CDTX) next earnings date is currently unknown.

  • Does Cidara Therapeutics pay dividends?

    No, Cidara Therapeutics does not pay dividends.

  • How much money does Cidara Therapeutics make?

    Cidara Therapeutics has a market capitalization of 165.31M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.6% to 63.91M US dollars.

  • What is Cidara Therapeutics's stock symbol?

    Cidara Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "CDTX".

  • What is Cidara Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Cidara Therapeutics?

    Shares of Cidara Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Cidara Therapeutics's key executives?

    Cidara Therapeutics's management team includes the following people:

    • Dr. Jeffrey L. Stein Ph.D. Pres, Chief Executive Officer & Executive Director(age: 70, pay: $837,530)
    • Dr. Taylor Sandison Chief Medical Officer(age: 53, pay: $593,850)
  • How many employees does Cidara Therapeutics have?

    As Jul 2024, Cidara Therapeutics employs 69 workers, which is 5% less then previous quarter.

  • When Cidara Therapeutics went public?

    Cidara Therapeutics, Inc. is publicly traded company for more then 10 years since IPO on 15 Apr 2015.

  • What is Cidara Therapeutics's official website?

    The official website for Cidara Therapeutics is cidara.com.

  • Where are Cidara Therapeutics's headquarters?

    Cidara Therapeutics is headquartered at 6310 Nancy Ridge Drive, San Diego, CA.

  • How can i contact Cidara Therapeutics?

    Cidara Therapeutics's mailing address is 6310 Nancy Ridge Drive, San Diego, CA and company can be reached via phone at 858 752 6170.

Cidara Therapeutics company profile:

Cidara Therapeutics, Inc.

cidara.com
Exchange:

NASDAQ

Full time employees:

69

Industry:

Biotechnology

Sector:

Healthcare

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

6310 Nancy Ridge Drive
San Diego, CA 92121

CIK: 0001610618
ISIN: US1717571079
CUSIP: 171757107